NCT01961960View on ClinicalTrials.gov

A Study to Evaluate Intramuscular ASP7374

PHASE3CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

InfluenzaVaccine

Interventions

BIOLOGICAL

ASP7374

intramuscular

Trial Locations (1)

Unknown

Kanto

All Listed Sponsors

lead

UMN Pharma Inc.

INDUSTRY

NCT01961960 - A Study to Evaluate Intramuscular ASP7374 | Biotech Hunter | Biotech Hunter